Item Type | Name |
Academic Article
|
Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125.
|
Academic Article
|
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.
|
Academic Article
|
An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial.
|
Academic Article
|
A novel MRI marker for prostate brachytherapy.
|
Academic Article
|
Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management.
|
Academic Article
|
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience.
|
Academic Article
|
Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.
|
Academic Article
|
Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
|
Academic Article
|
Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy.
|
Academic Article
|
Magnetic resonance imaging-based treatment planning for prostate brachytherapy.
|
Academic Article
|
Long-term tumor control after brachytherapy for base-of-prostate cancer.
|
Academic Article
|
Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
|
Academic Article
|
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy.
|
Academic Article
|
Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy.
|
Concept
|
Brachytherapy
|
Academic Article
|
Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer.
|
Academic Article
|
MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer.
|
Academic Article
|
Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy.
|
Academic Article
|
MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy.
|
Academic Article
|
Establishing high-quality prostate brachytherapy using a phantom simulator training program.
|
Academic Article
|
Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil.
|
Academic Article
|
Brachytherapy dose-volume histogram commissioning with multiple planning systems.
|
Academic Article
|
Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
|
Academic Article
|
Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
|
Academic Article
|
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.
|
Academic Article
|
Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy
|
Academic Article
|
Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing
|
Academic Article
|
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients
|
Academic Article
|
Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy
|
Academic Article
|
Brachytherapy dose-volume histogram commissioning with multiple planning systems
|
Academic Article
|
Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy
|
Academic Article
|
Permanent prostate brachytherapy pubic arch evaluation with diagnostic magnetic resonance imaging.
|
Academic Article
|
Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.
|
Academic Article
|
Development of a magnetic resonance imaging protocol to visualize encapsulated contrast agent markers in prostate brachytherapy recipients: initial patient experience.
|
Academic Article
|
Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy.
|
Academic Article
|
Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer.
|
Academic Article
|
Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers.
|
Academic Article
|
Magnetic resonance imaging basics for the prostate brachytherapist.
|
Academic Article
|
Comparison of prostate distortion by inflatable and rigid endorectal MRI coils in permanent prostate brachytherapy imaging.
|
Academic Article
|
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes.
|
Academic Article
|
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study.
|
Academic Article
|
Development and clinical implementation of SeedNet: A sliding-window convolutional neural network for radioactive seed identification in MRI-assisted radiosurgery (MARS).
|
Academic Article
|
MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy.
|
Academic Article
|
Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy.
|
Academic Article
|
Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy.
|
Academic Article
|
Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy.
|
Academic Article
|
Development, implementation, and outcomes of a simulation-based medical education (SBME) prostate brachytherapy workshop for radiation oncology residents.
|
Academic Article
|
Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study.
|
Academic Article
|
The American Brachytherapy Society prostate brachytherapy LDR/HDR simulation workshops: Hands-on, step-by-step training in the process of quality assurance.
|
Academic Article
|
Improving efficiency and reducing costs of MRI-Guided prostate brachytherapy using Time-Driven Activity-Based costing.
|
Academic Article
|
Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry.
|
Academic Article
|
Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry.
|
Academic Article
|
The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries.
|